| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77e575095d5c3a5b28fd9e6bb970b43c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae7580e37beb28efbb60df2de0ac582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760b359d344edd8c5aa1f481b60b559e |
| publicationDate |
2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015338399-A1 |
| titleOfInvention |
Methods for diagnosing and monitoring disease by directly quantifying disease modified biomolecules |
| abstract |
Assays for diagnosing or monitoring a disease of interest are provided. The assays detect disease modified bjomolecules (DMBs) in a direct manner by the sequential use of agents with differing specificities. In an exemplary embodiment, the agents are antibodies and the first antibody is specific for a biomolecule that may be modified during the course of 10 the disease, and detects such biomolecules, whether modified or not The second antibody detects only biomolecules that have been modified. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016363580-A1 |
| priorityDate |
2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |